Try it
Pharmacology · Chemotherapy: glucarpidase
Sample itemA patient treated with high-dose methotrexate has rising creatinine, a markedly elevated methotrexate level at 48 hours and mucositis despite leucovorin. Which agent rapidly degrades methotrexate?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Glucarpidase
Glucarpidase is a recombinant carboxypeptidase that converts methotrexate to inactive metabolites, rescuing patients with delayed clearance and renal failure. Mesna binds acrolein from ifosfamide, amifostine protects against cisplatin renal toxicity and dexrazoxane protects against anthracycline cardiotoxicity.
Option by option
A. Dexrazoxane
Dexrazoxane protects the heart from doxorubicin.
B. Amifostine
Amifostine is a cytoprotectant for cisplatin.
C. Mesna
Mesna protects against haemorrhagic cystitis.
D. Glucarpidase (correct)
Correct. Glucarpidase hydrolyses methotrexate.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?